Zinc Gluconate
Zinc
Sold as COLD · Cold-EEZE Cold Remedy · Cold-EEZE Cold Remedy…
- Drug class
- Zinc
- Availability
- Over-the-counter
- Routes
- Oral
- Markets covered
- 2
- Products on record
- 8
- FDA reports (12 mo)
- 2,148
Overview
Plain-language summary, compiled from the cited regulatory records
Zinc Gluconate is an active ingredient classified as Zinc (A12CB) [1]. It is approved for use in reducing the duration of the common cold and lessening the severity of cold symptoms, including cough, sore throat, nasal congestion, post-nasal drip, and hoarseness [1].
This ingredient is available under various brand names, such as Cold-EEZE Cold Remedy, Cold-EEZE Cold Remedy UltraMELT Chews, and COLD [1]. In the past 12 months, there have been 2,148 adverse event reports associated with products containing Zinc Gluconate [2]. The most frequently reported reactions include fatigue, off-label use, nausea, headache, and dyspnea [2].
This is not medical advice. Consult a qualified healthcare professional.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| US United States | FDA | 6 | May 1, 2026 |
| GB United Kingdom | MHRA | 2 | February 20, 2026 |
USUnited States· FDA
6 products
Uses
Uses reduces the duration of the common cold reduces the severity of cold symptoms: cough, sore throat, nasal congestion, post nasal drip and/or hoarseness
How to take
GBUnited Kingdom· MHRA
2 products
Uses
A traditional herbal medicinal product used to relieve the symptoms of the common cold and influenza type infections based on traditional use only.
How to take
Drug interactions
Known interactions involving Zinc Gluconate. Select one for details. This list is informational and not a complete interaction checker.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]FDA DailyMed · 016937dd-6599-84… · revised May 1, 2026 [PDF]
- [2]MHRA (UK) · THR022310011 · revised February 20, 2026
- [3]OpenFDA adverse-event reports (US), 12 months ending June 4, 2026.
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.